Source link : https://www.newshealth.biz/health-news/purpose-1-lenacapavir-results-highly-anticipated/
The HIV community will soon get to look at data from the PURPOSE 1 clinical trial of twice-yearly lenacapavir for preexposure prophylaxis after interim results showed it was 100% effective in preventing infection. Linda-Gail Bekker, MBChB, director of the Desmond Tutu HIV Center at the University of Cape Town, South Africa, will present the results […]
Author : News Health
Publish date : 2024-07-17 18:40:45
Copyright for syndicated content belongs to the linked Source.
Categories